Skip to content
10-Q

Quarterly Report

XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

0001213900-19-016052

← back to feed
Filed
Aug 15, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 8, 2019 46.27M sh
Capex Q2 2019 · Jun 30, 2019 $52.34K
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$7.98M
Operating Cash Flow restated Q2 2019 · Jun 30, 2018 −$3.01M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $1.19M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $4.75M
Cash And Equivalents restated Q2 2019 · Jun 30, 2018 $788.96K
Cash And Equivalents restated Q2 2019 · Dec 31, 2017 $100.34K
Stockholders Equity Q2 2019 · Jun 30, 2019 −$15.04M
Stockholders Equity Q2 2019 · Mar 31, 2019 −$28.29M
Stockholders Equity Q2 2019 · Dec 31, 2018 −$20.09M
Current Liabilities Q2 2019 · Jun 30, 2019 $17.05M
Current Liabilities Q2 2019 · Dec 31, 2018 $17.65M
Total Liabilities Q2 2019 · Jun 30, 2019 $17.05M
Total Liabilities Q2 2019 · Dec 31, 2018 $17.65M
Current Assets Q2 2019 · Jun 30, 2019 $1.35M
Current Assets Q2 2019 · Dec 31, 2018 $5.02M
Total Assets Q2 2019 · Jun 30, 2019 $2.01M
Total Assets Q2 2019 · Dec 31, 2018 $5.46M
Sga Expense Q2 2019 · Jun 30, 2019 $1.44M
Sga Expense Q2 2019 · Jun 30, 2019 $10.22M
Sga Expense Q2 2019 · Jun 30, 2018 $745.29K
Sga Expense Q2 2019 · Jun 30, 2018 $848.76K
Rd Expense Q2 2019 · Jun 30, 2019 $1.57M
Rd Expense Q2 2019 · Jun 30, 2019 $6.89M
Rd Expense Q2 2019 · Jun 30, 2018 $3.87M
Rd Expense Q2 2019 · Jun 30, 2018 $4.34M
Net Income Q2 2019 · Jun 30, 2019 −$3.05M
Net Income Q2 2019 · Jun 30, 2019 −$17.2M
Net Income Q2 2019 · Mar 31, 2019 −$14.14M
Net Income Q2 2019 · Jun 30, 2018 −$4.71M
Net Income restated Q2 2019 · Jun 30, 2018 −$5.33M
Operating Income Q2 2019 · Jun 30, 2019 −$3.03M
Operating Income Q2 2019 · Jun 30, 2019 −$17.16M
Operating Income Q2 2019 · Jun 30, 2018 −$4.72M
Operating Income restated Q2 2019 · Jun 30, 2018 −$5.34M